pharma.pet
0667.702.666 · rovalta.com · 09/11/2026
pharma.pet
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOpharma.pet is a Private limited company incorporated in 2016. Its main activity is: Wholesale of other food, including fish, crustaceans and molluscs. Its registered office is in Brasschaat.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0667.702.666
- Incorporation
- 14/12/2016
- Legal form
- Private limited company
- Registered office
- Mollei 131
2930 Brasschaat · FlandreSee on map - Contributed capital
- 256 200,00 €
- Latest accounts
- 31/12/2024
- Average workforce
- 0,0 ETP
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -35,1 k € | +91.9% | -431,5 k € | -114% | -201,5 k € | -1897% | 11,2 k € | -36.8% | 17,7 k € |
| EBITDA | -35,1 k € | +92.5% | -466,5 k € | -72.6% | -270,4 k € | -2739% | 10,2 k € | -40.4% | 17,2 k € |
| Operating result | -160,9 k € | +72.3% | -581,3 k € | -52.5% | -381,2 k € | -983% | -35,2 k € | -24.6% | -28,2 k € |
| Net result | -157 k € | +72.9% | -579,6 k € | -458% | 162 k € | +502% | -40,3 k € | -20.4% | -33,5 k € |
| Balance sheet | |||||||||
| Equity | -414,4 k € | -61.0% | -257,5 k € | -180% | 322,2 k € | +101% | 160,2 k € | -20.1% | 200,5 k € |
| Total assets | 1,6 M € | +8.8% | 1,5 M € | +1.3% | 1,5 M € | -10.2% | 1,7 M € | +56.0% | 1,1 M € |
| Cash | 86,8 € | -92.4% | 1,1 k € | +181% | 405,3 € | – | 14,3 k € | ||
| Debts | 2,1 M € | +16.4% | 1,8 M € | +51.4% | 1,2 M € | -22.1% | 1,5 M € | +73.8% | 860,9 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 15/12/2016Manager15/12/2016 → 2018 accountsended |
Other companies at this address
Mollei 131 2930 Brasschaat| Company | CBE no. |
|---|---|
CC - INVEST● Active | 0479.368.456 |
CMG● Active | 0861.686.434 |
VERO - IMAGE● Active | 0459.659.937 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/07/2018 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 18 months |
| Filing date | 02/12/2025 | 31/01/2025 | 09/10/2023 | 01/08/2022 | 25/06/2021 | 25/11/2020 |
| General meeting | 23/09/2025 | 24/01/2025 | 09/06/2023 | 10/06/2022 | 11/06/2021 | 20/08/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 23/09/2025 | 02/12/2025 | Dutch | |
| Abridged model | 31/12/2023 | 24/01/2025 | 31/01/2025 | Dutch | |
| Abridged model | 31/12/2022 | 09/06/2023 | 09/10/2023 | Dutch | |
| Abridged model | 31/12/2021 | 10/06/2022 | 01/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 11/06/2021 | 25/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 20/08/2020 | 25/11/2020 | Dutch | |
| Abridged model | 30/06/2018 | 15/12/2018 | 11/02/2019 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 15/12/2016Manager15/12/2016 → 2018 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates07/05/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Capital / shares22/11/2018KAPITAAL - AANDELEN - ALGEMENE VERGADERING - BOEKJAAR
- Registered office21/03/2018MAATSCHAPPELIJKE ZETEL
- Other24/01/2018BUITENGEWONE ALGEMENE VERGADERING: WIJZIGING !
- Other16/12/2016Uit een akte verleden voor Wouter NOUWKENS, geassocieerd notaris te Malle op dertien december
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Mollei 131, 2930 BrasschaatCurrent | accounts 2021 → 2024 | Accounts 2024 · 2025-00578071 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| pharma.petCurrent | accounts 2021 → 2024 | Accounts 2024 · 2025-00578071 |
Events
- 2024Annual accounts 2024-157 k €↑
- 2023Annual accounts 2023-579,6 k €↓
- 2022Annual accounts 2022162 k €↑
- 2021Annual accounts 2021-40,3 k €↓
- 2020Annual accounts 2020-33,5 k €↓
- 2019Annual accounts 2019-13,3 k €↓
- 2018Annual accounts 2018-8,9 k €
- 14/12/2016IncorporationPrivate limited company